Prolia is a medicine used to treat osteoporosis in women after menopause, whose active substance is denosumab, a substance that prevents the breakdown of the body’s bones, thus helping to combat osteoporosis. Prolia is produced by Amgen’s lab.
Understand what monoclonal antibodies are and what diseases they treat, what monoclonal antibodies are and what they are used for.
- Prolia is indicated to treat osteoporosis in women after menopause.
- Reducing the risk of fractures of the spine.
- Hips and other bones.
- It can also be used to treat bone loss resulting from a reduction in hormone testosterone levels.
- Caused by surgery or medications.
- Treatment in prostate cancer patients.
Each injection of Prolia costs about 700 reais
How to use Prolia is to take a 60 mg syringe, given once every 6 months, in a single injection under the skin.
Side effects of Prolia may include: pain when urinating, respiratory infection, pain and tingling in the lower extremities, constipation, allergic skin reaction, pain in the arm and leg, fever, vomiting, otitis or low calcium levels.
Prolia is contraindicated in patients with hypersensitivity to any of the components of the formula, allergy to latex, kidney problems or cancer, and should not be taken by people with low levels of calcium in the blood.
Patients who have undergone chemotherapy or radiation therapy should also not use this medicine.